Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens

Cancer Science

Volumn 99, Issue 11, 2008, Pages 2244-2251

  Fujita, Hayato ^a   Ohuchida, Kenoki ^a   Mizumoto, Kazuhiro ^a,b   Egami, Takuya ^a   Miyasaka, Yoshihiro ^a   Yamaguchi, Hiroshi ^a,c   Yu, Jun ^a   Cui, Lin ^a   Onimaru, Manabu ^a   Takahata, Shunichi ^a   Tsuneyoshi, Masazumi ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MOLECULAR MARKER; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; FEASIBILITY STUDY; GENETIC DAMAGE; HUMAN; HUMAN CELL; LASER CAPTURE MICRODISSECTION; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; PANCREAS CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; RNA FRAGMENTATION; SENSITIVITY AND SPECIFICITY; TARGET CELL;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TELOMERASE;

EID: 55449090917     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00930.x     Document Type: Article

References (47)

1. Baloch Z, Carayon P, Conte-Devolx B et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3-126.
2. Boerner S, Fornage BD, Singletary E, Sneige N. Ultrasound-guided fine-needle aspiration (FNA) of nonpalpable breast lesions: A review of 1885 FNA cases using the National Cancer Institute-supported recommendations on the uniform approach to breast FNA. Cancer 1999; 87: 19-24.
3. Mittendorf EA, Tamarkin SW, McHenry CR. The results of ultrasound-guided fine-needle aspiration biopsy for evaluation of nodular thyroid disease. Surgery 2002; 132: 648-53; discussion 653-44.
4. Maier U, Simak R, Neuhold N. The clinical value of urinary cytology: 12 years of experience with 615 patients. J Clin Pathol 1995; 48: 314-17.
5. Uehara H, Nakaizumi A, Tatsuta M et al. Diagnosis of carcinoma in situ of the pancreas by peroral pancreatoscopy and pancreatoscopic cytology. Cancer 1997; 79: 454-61.
6. Yamaguchi T, Shirai Y, Ishihara T et al. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: Significance of sampling by peroral pancreatoscopy. Cancer 2005; 104: 2830-6.
7. Segev DL, Clark DP, Zeiger MA, Umbricht C. Beyond the suspicious thyroid fine needle aspirate. A review. Acta Cytol 2003; 47: 709-22.
8. Yang GC, Liebeskind D, Messina AV. Should cytopathologists stop reporting follicular neoplasms on fine-needle aspiration of the thyroid? Cancer 2003; 99: 69-74.
9. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
10. Ohuchida K, Mizumoto K, Ishikawa N et al. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: Analysis of 100 samples of pancreatic juice from consecutive patients. Cancer 2004; 101: 2309-17.
11. Suehara N, Mizumoto K, Tanaka M et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res 1997; 3: 2479-83.
12. Uehara H, Nakaizumi A, Tatsuta M et al. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: Comparison with K-ras mutations. Am J Gastroenterol 1999; 94: 2513-18.
13. Yoshida K, Sugino T, Tahara H et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997; 79: 362-9.
14. Ohuchida K, Mizumoto K, Ogura Y et al. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Clin Cancer Res 2005; 11: 2285-92.
15. Gertler R, Rosenberg R, Stricker D et al. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma. Cancer 2002; 95: 2103-11.
16. Meyerson M, Counter CM, Eaton EN et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785-95.
17. Lehner R, Enomoto T, McGregor JA et al. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol Oncol 2002; 84: 120-5.
18. Saji M, Xydas S, Westra WH et al. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res 1999; 5: 1483-9.
19. Umbricht CB, Conrad GT, Clark DP et al. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors. Clin Cancer Res 2004; 10: 5762-8.
20. Kirkpatrick KL, Ogunkolade W, Elkak AE et al. hTERT expression in human breast cancer and non-cancerous breast tissue: Correlation with tumour stage and c-Myc expression. Breast Cancer Res Treat 2003; 77: 277-84.
21. Jong HS, Park YI, Kim S et al. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 1999; 86: 559-65.
22. Itoi T, Shinohara Y, Takeda K et al. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers. Int J Mol Med 2001; 7: 281-7.
23. Hara H, Yamashita K, Shinada J, Yoshimura H, Kameya T. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer. Lung Cancer 2001; 34: 219-26.
24. Ito H, Kyo S, Kanaya T et al. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Clin Cancer Res 1998; 4: 2807-10.
25. Liu BC, LaRose I, Weinstein LJ, Ahn M, Weinstein MH, Richie JP. Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection. Cancer 2001; 92: 1943-8.
26. Ohuchida K, Mizumoto K, Yamada D et al. Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer. Clin Cancer Res 2006; 12: 2066-9.
27. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082-6.
28. Hiyama K, Hirai Y, Kyoizumi S et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-5.
29. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996; 106: 759-65.
30. Tachikawa T, Irie T. A new molecular biology approach in morphology: basic method and application of laser microdissection. Med Electron Microsc 2004; 37: 82-8.
31. Ohuchida K, Mizumoto K, Murakami M et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 2004; 64: 3215-22.
32. Papanicolaou GN. The cancer-diagnostic potential of uterine exfoliative cytology. CA Cancer J Clin 1957; 7: 124-35.
33. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
34. Antonov J, Goldstein DR, Oberli A et al. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 2005; 85: 1040-50.
35. Lekanne Deprez RH, Fijnvandraat AC, Ruijter JM, Moorman AF. Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions. Anal Biochem 2002; 307: 63-9.
36. Lewis F, Maughan NJ, Smith V, Hillan K, Quirke P. Unlocking the archive -gene expression in paraffin-embedded tissue. J Pathol 2001; 195: 66-71.
37. Ohuchida K, Mizumoto K, Fujita H et al. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice. J Pathol 2006; 210: 42-8.
38. Ohuchida K, Mizumoto K, Ishikawa N et al. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res 2005; 11: 7785-93.
39. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.
40. Mills NE, Fishman CL, Scholes J, Anderson SE, Rom WN, Jacobson DR. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J Natl Cancer Inst 1995; 87: 1056-60.
41. Tada M, Ohashi M, Shiratori Y et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996; 110: 227-31.
42. Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Cancer Lett 2003; 191: 223-7.
43. Genest DR, Dean B, Lee KR, Sheets E, Crum CP, Cibas ES. Qualifying the cytologic diagnosis of 'atypical squamous cells of undetermined significance'affects the predictive value of a squamous intraepithelial lesion on subsequent biopsy. Arch Pathol Lab Med 1998; 122: 338-41.
44. Deshpande V, McKee GT. Analysis of atypical urine cytology in a tertiary care center. Cancer 2005; 105: 468-75.
45. Fend F, Raffeld M. Laser capture microdissection in pathology. J Clin Pathol 2000; 53: 666-72.
46. Fink L, Seeger W, Ermert L et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998; 4: 1329-33.
47. Schutze K, Lahr G. Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol 1998; 16: 737-42.